Vitalhub Corp. (TSE:VHI - Get Free Report)'s stock price hit a new 52-week high during mid-day trading on Tuesday . The stock traded as high as C$13.70 and last traded at C$13.49, with a volume of 110124 shares traded. The stock had previously closed at C$13.40.
Analyst Upgrades and Downgrades
VHI has been the subject of several analyst reports. National Bank Financial raised shares of Vitalhub to a "strong-buy" rating in a report on Monday, June 9th. Raymond James Financial boosted their price target on shares of Vitalhub from C$13.50 to C$14.00 and gave the stock an "outperform" rating in a research note on Friday, June 20th. National Bankshares set a C$14.00 target price on Vitalhub and gave the stock an "outperform" rating in a research report on Tuesday, June 10th. TD Securities increased their price target on Vitalhub from C$13.00 to C$14.00 and gave the company a "buy" rating in a research note on Monday, March 31st. Finally, Scotiabank lifted their price objective on Vitalhub from C$14.00 to C$14.50 and gave the stock an "outperform" rating in a research note on Friday, June 20th. Six investment analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of "Buy" and a consensus price target of C$13.25.
Get Our Latest Report on Vitalhub
Vitalhub Stock Performance
The company has a 50 day moving average of C$11.23 and a two-hundred day moving average of C$10.72. The stock has a market capitalization of C$722.13 million, a PE ratio of 217.13, a P/E/G ratio of 1.18 and a beta of 1.26.
Insider Transactions at Vitalhub
In other news, Director Francis Nelson Shen purchased 25,000 shares of the company's stock in a transaction that occurred on Friday, May 16th. The stock was purchased at an average cost of C$10.23 per share, for a total transaction of C$255,750.00. Corporate insiders own 18.57% of the company's stock.
Vitalhub Company Profile
(
Get Free Report)
Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Vitalhub, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vitalhub wasn't on the list.
While Vitalhub currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
